Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13618120 | 0.85 | — | — | |
| SCHEMBL13942182 | 0.83 | HSD17B10 (0.36) | HSD17B10TDP1LMNA | |
| SCHEMBL11063082 | 0.83 | HSD17B10 (0.32) | HSD17B10TDP1 | |
| SCHEMBL28702901 | 0.81 | — | — | |
| SCHEMBL9714708 | 0.81 | — | — | |
| SCHEMBL9393419 | 0.79 | ADRB2 (0.45) | THRBLMNACA1CA2 | |
| SCHEMBL27754438 | 0.78 | HSD17B10 (0.44) | HSD17B10TDP1LMNA | |
| SCHEMBL54730 | 0.77 | THRB (0.50) | HSD17B10THRBTDP1LMNACA1 | |
| SCHEMBL2387219 | 0.76 | HSD17B10 (0.37) | HSD17B10TDP1 | |
| SCHEMBL17789890 | 0.76 | HSD17B10 (0.32) | HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1543088-B1 | NOVEL ADHESIVES COMPRISING DIACETALS | CLARIANT SPECIALTY FINE CHEM (FR) | 2007-11-07 | — | — | EP | claimed |
| WO-2006092716-A1 | CASTING COMPOSITION | CLARIANT (FRANCE) (FR) | 2006-09-08 | — | — | WO | claimed |
| US-20060194918-A1 | Novel adhesives comprising diacetals | CLARIANT (FRANCE) (FR) | 2006-08-31 | — | — | US | claimed |
| EP-2598550-B1 | BINDER SYSTEM BASED ON POLYURETHANE FOR PRODUCING CORES AND CASTING MOLDS USING CYCLIC FORMALDEHYDES, MOLDING MATERIAL MIXTURE, AND METHOD | ASK CHEMICALS GMBH (DE) | 2014-12-31 | — | — | EP | disclosed |
| US-20140300031-A1 | BINDER SYSTEM BASED ON POLYURETHANE FOR PRODUCING CORES AND CASTING MOLDS USING CYCLIC FORMALS, MOLDING MATERIAL MIXTURE, AND METHOD | ASK CHEMICALS GMBH (DE) | 2014-10-09 | — | — | US | disclosed |
| EP-1543088-B1 | NOVEL ADHESIVES COMPRISING DIACETALS | CLARIANT SPECIALTY FINE CHEM (FR) | 2007-11-07 | — | — | EP | disclosed |
| WO-2006092716-A1 | CASTING COMPOSITION | CLARIANT (FRANCE) (FR) | 2006-09-08 | — | — | WO | disclosed |
| US-20060194918-A1 | Novel adhesives comprising diacetals | CLARIANT (FRANCE) (FR) | 2006-08-31 | — | — | US | disclosed |
| CN-1541993-A | Process for continuously preparing acetals of alpha, beta-dicarbonyl compounds | 1 | 2004-11-03 | — | — | CN | disclosed |
| US-20040186304-A1 | Process for continuously preparing acetals of alpha, beta-dicarbonyl compounds | DEGUSSA AG (DE) | 2004-09-23 | — | — | US | disclosed |
| EP-1460052-A1 | Process for the continuous preparation of acetals of alpha,beta-dicarbonyl compounds | Degussa AG (DE) | 2004-09-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040186304-A1 | Process for continuously preparing acetals of alpha, beta-dicarbonyl compounds | CRABP2, DHCR24, CBR1 | HSD17B10 363/4885THRB 508/4885TDP1 4713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.